comprehensive -WSS

comprehensive

author：entertainment 2025-08-28 13:04:11 - browse：8

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Neuroscience renaissance leads to new crop of psychiatric drugs

focus

WSS

Are embryos people? Reproductive medicine's future depends on the answer

Change Healthcare cyberattack shows risk of industry consolidation

Surgery pushed Ben Carson to fame

AstraZeneca stays mum on Medicare drug pricing negotiations

Medicare isn't yet testing food as medicine

Texas Medical Board asked to define abortion emergency exception

leisure time

comprehensive

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Bernie brings in new pharma CEOs to talk drug prices

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Johnson & Johnson sued for allegedly overpaying for workers' drugs

The high cost of giving birth even with insurance

AI gets buy

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Adopting new red light myopia treatments may be short

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

entertainment

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

CDC advisory group OKs chikungunya vaccine

Cano Health’s bankruptcy is a warning for Medicare Advantage

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Bernie brings in new pharma CEOs to talk drug prices

leisure time

explore

focus

explore